Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 Mg Alone

Trial Profile

Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 Mg Alone

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2014

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Amlodipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Europe
  • Most Recent Events

    • 20 Jun 2011 Mean 24-hour ambulatory BP results (stratified by baseline ABP) presented at the 21st European Meeting on Hypertension.
    • 20 Jun 2011 Target blood pressure results presented at the 21st European Meeting on Hypertension.
    • 13 Jun 2009 Results were presented at the 19th European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top